IBF as a formalin substitute fixative in prostate biopsy pathology [2]

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 1, 2006, Pages 13-14

  Trpkov, Kiril ^a   Renault, Peter ^a   Yilmaz, Asli ^a   Ali Ridha, Nihad ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Oshawa General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIXATIVE; FORMALDEHYDE;

CELL STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LETTER; NUCLEOLUS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TISSUE FIXATION;

BIOPSY; FIXATIVES; FORMALDEHYDE; HUMANS; MALE; PATHOLOGY, SURGICAL; PROSTATIC DISEASES; TISSUE FIXATION;

EID: 30444448213     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Titford ME, Horenstein MG. Histomorphologic assessment of formalin substitute fixatives for diagnostic surgical pathology. Arch Pathol Lab Med. 2005;129:502-506.
2. Murphy WM, Ramsey J, Soloway MS. A better nuclear fixative for diagnostic bladder and prostate biopsies. J Urol Pathol. 1993;1:79-87.
3. Arnold MM, Srivastava S, Fredenburgh J, Stockard CR, Myers RB, Grizzle WE. Effect of fixation and tissue processing on immunohistochemical demonstration of specific antigens. Biotech Histochem. 1996;71:224-230.
4. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34βE12 immunostaining of prostatic tissue. Mod Pathol. 1999;12:472-478.
5. Trpkov K, Chiu E. Utility of cytokeratin 5/6 and AMACR as a routine immunopanel for the diagnosis of prostate cancer on needle core biopsy. Mod Pathol. 2004;17(suppl 1):181A.